Invention Grant
- Patent Title: Anti-HtrA1 antibodies and methods of use thereof
-
Application No.: US15336171Application Date: 2016-10-27
-
Publication No.: US10421821B2Publication Date: 2019-09-24
- Inventor: Robert F. Kelley , Daniel K. Kirchhofer , Joyce Lai , Chingwei V. Lee , Wei-Ching Liang , Michael T. Lipari , Kelly M. Loyet , Tao Sai , Menno Van Lookeren Campagne , Yan Wu , Germaine Fuh
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Clark & Elbing LLP
- Agent Karen L. Elbing
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; C07K16/40
Abstract:
The present invention provides anti-HtrA1 antibodies (including bispecific anti-HtrA1 anti-Factor D antibodies) and methods of making and using the same, for example, in methods of treating HtrA1-associated disorders, ocular disorders, and/or complement-associated disorders.
Public/Granted literature
- US20170145113A1 ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF Public/Granted day:2017-05-25
Information query
